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To determine which respiratory viruses circulate among 
conﬁ   ned dogs, we analyzed nasal and pharyngeal swab 
specimens from shelter dogs with acute respiratory dis-
ease. An unknown virus was isolated. Monoclonal antibody 
testing indicated that it was probably a pneumovirus. PCR 
and sequence analysis indicated that it was closely related 
to murine pneumovirus.
D
omestic dogs housed in close conﬁ  nement, as in ken-
nels or animal shelters, are often involved in outbreaks 
of acute respiratory disease (1,2). To determine which vi-
ruses are associated with these outbreaks, we studied 200 
dogs in 2 animal shelters in the northeastern United States 
during 2008–2009.
The Study
Nasal and pharyngeal swab specimens were collected 
from the dogs, and swab eluate extracts were prepared. 
Pooled extracts were added to monolayer cultures of ca-
nine A72 cells (American Type Culture Collection, CRL-
1542).  After 3 passages in culture, cells in some of the 
ﬂ  asks showed subtle cytopathic changes. After continued 
passage, small foci of rounded cells developed, and rapid 
and progressive cell death throughout the ﬂ  ask ensued in a 
pattern uncharacteristic of the viruses commonly isolated 
from dogs. Testing these cultures with a panel of diagnos-
tic reagents speciﬁ  c for common canine respiratory agents 
failed to identify a known virus. Immunoﬂ  uorescence as-
says (IFAs) ultimately detected 13 positive cultures over a 
4-month period when a monoclonal antibody (MAb) pool 
against human respiratory syncytial virus (RSV) (VP-R151, 
Vector Laboratories, Burlingame, CA, USA) was used. We 
have commonly used this antibody preparation to detect 
bovine RSV.  The staining pattern included ﬁ  lamentous 
membrane-bound and free-ﬂ  oating virions and cytoplasmic 
inclusions, typical of the pattern in RSV-infected cells.
After obtaining IFA results, we attempted to amplify 
a fragment of the nucleocapsid gene (N) from the virus by 
using PCR primers designed on the basis of an alignment 
of human, bovine, and ovine RSV sequences. This attempt 
was unsuccessful (data not shown). Stocks of the individual 
MAbs in the anti-RSV pool and their speciﬁ  cities were ob-
tained from the manufacturer and used for IFA (Figure). 
MAb 2G122 (P protein–speciﬁ  c) stained primarily inclu-
sions and gave a relatively uniform membrane-associated 
signal. Staining with MAb 5H5N (M2 protein–speciﬁ  c) 
illuminated virions and inclusions. No ﬂ  uorescence was 
noted with MAbs 1C3 (N protein–speciﬁ  c) or 5A6 (F pro-
tein–speciﬁ  c). All 4 individual MAbs recognized bovine 
RSV by IFA (data not shown). Recognition of the canine 
virus by only 2 of 4 MAbs and the inability to amplify a 
conserved region of the RSV genome suggested that it was 
related to, but unlikely to be, RSV.
To elucidate sequence information from 1 of the 13 
isolates, we used a consensus-degenerate hybrid oligonu-
cleotide primer algorithm to design degenerate PCR prim-
ers based on highly conserved amino acid sequences within 
multiple sequence alignments of all viruses in the subfam-
ily Pneumovirinae (3). Speciﬁ  c regions within the L (poly-
merase) and N genes were targeted (Table). Sequencing of 
the reaction products and BLAST (www.ncbi.nlm.nih.gov/
blast/Blast.cgi) analysis showed the virus to be closely re-
lated to murine pneumovirus (MPV), traditionally known 
as pneumonia virus of mice. Two L-gene PCR products 
were found to be 96%–97% identical to MPV, and an N 
gene fragment was 96% identical (Table).
Discussion and Conclusions
MPV is 1 of only 3 virus species classiﬁ  ed in the fam-
ily  Paramyxoviridae, subfamily Pneumovirinae, genus 
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Figure. Slides showing immunoﬂ   uorescence of A72 cells with 
human respiratory syncytial virus monoclonal antibodies (MAbs). A) 
MAb 2G122 on infected cells. B) MAb 2G122 on uninfected cells. 
C) MAb 5H5N on infected cells. D) MAb 5H5N on uninfected cells. 
Primary MAb stocks were used as obtained from the manufacturer 
at a dilution of 1:100. The red background is produced by 
counterstaining with Evans blue dye. Original magniﬁ  cation ×200.Pneumovirus. Human RSV is the type species and is close-
ly related to bovine RSV; MPV is more distantly related. 
For example, the N protein nucleotide sequences of human 
and bovine RSV are ≈94% identical to each other but only 
60% identical to those of MPV. Only 2 strains of MPV, 
J3666 and Strain 15, have been fully sequenced, and they 
are 99.7% identical at the nucleotide level.
The nucleotide identity between virus isolated from the 
dogs and MPV was consistently >95% throughout the gene 
regions examined. Because the degenerate primers used 
were designed to cover regions that are generally highly 
conserved, regions of the genome that are typically more 
variable in other pneumoviruses may show greater differ-
ences between the canine pneumovirus and MPV. Of the 
conserved regions sequenced, amino acid identities were 
70% (N), 55% (L fragment no. 1), and 72% (L fragment 
no. 2) when aligned with the same regions of human RSV, 
so ﬁ  nding cross-reactivity between human RSV MAbs and 
the newly isolated virus is not completely unexpected. Se-
rologic cross-reactivity between RSV and MPV has been 
previously observed. Gimenez et al. (4) did not ﬁ  nd recog-
nition of MPV when they used 2 anti–human RSV MAbs, 
but they did observe recognition of MPV N protein when 
they used mouse anti–human RSV serum in immunoblot 
assays. Ling and Pringle (5) showed cross-reactivity of N 
proteins with polyclonal serum and cross-reactivity with a 
MAb that recognized P in immunoblot assays. Although 
the MAbs used in this study had been extensively tested for 
reactivity against a panel of 13 viruses, including several 
members of the family Paramyxoviridae (6,7), they were 
probably not tested for cross-reactivity against MPV be-
cause it is not a known human pathogen. The ﬁ  nding that 
reagents used to identify human RSV showed strong rec-
ognition of a closely related but distinct virus highlights 
the need for caution when interpreting research studies and 
conducting diagnostic evaluations.
The isolation of a previously unknown virus from dogs 
does not imply disease causation. However, comparison 
with MPV leads to speculation that the virus isolated in this 
study may have pathogenic potential. MPV is commonly 
known to infect laboratory rodent colonies, and serologic 
evidence points to infection of several wild rodent species. 
However, little is known about MPV epidemiology, such as 
whether MPV has multiple natural hosts or whether closely 
related viruses are circulating in other species. Neutralizing 
antibodies to MPV in other mammalian species, including 
humans, were ﬁ  rst reported in the 1940s (8,9), and  more 
recently, high prevalence of neutralizing antibodies but 
low (3%–4%) association with clinical disease in humans 
has been reported (10). Natural infection of rodents may 
be subclinical or latent. Sequelae to experimental infection 
in laboratory mice can vary from asymptomatic to severe 
disease with high morbidity and mortality rates. Pathogenic 
strains, including J3666 and Strain 15, can produce severe 
pneumonia and death in 6–10 days after mouse inoculation 
with a low dose (11,12). The pathogenicity or lack thereof 
may depend on the virus and on the mouse strain (13).
Questions remain as to whether this newly isolated vi-
rus commonly infects dogs and, if so, why it has not been 
previously isolated. Perhaps the strain that was circulating 
in these particular animal shelters is more easily isolated in 
culture. Or, because the initial cytopathic changes observed 
with these isolates were subtle, they could easily have been 
missed. Outbreaks of acute respiratory disease in dogs of-
ten involve multiple pathogens. As anticipated, other vi-
ruses, primarily canine inﬂ  uenza and parainﬂ  uenza viruses, 
were isolated during the study, often from the same animals 
that carried the pneumovirus. Work is ongoing to further 
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Table. Partial gene locations of virus isolated from dogs with respiratory disease and relatedness to other pneumoviruses* 
Region sequenced†
 
PCR primers (5ƍ ĺ 3ƍ) and aa target 
sequences in pneumoviruses 
% Identity to 
MPV, nt, aa† 
% Identity to 
HRSV, nt, aa‡ 
% Identity to 
HMPV, nt, aa§ 
N gene,¶ nt 852–1182 (331 bp)  P1R: ggaactcgggggcgaayttytccat 
target: MEKFAPEFH 
N276F: tccgtgcaggccgaratggarcarg 
target: SVQAEMEQV 
96.4, 96.3  68.5, 70.1  56.5, 54.1 
L gene, no. 1,¶ nt 1143–1452 (310 
bp) 
L428F: ccggatcttcggccayccnatggt 
target: RIFGHPMV 
L538R: ttcttaggaggggagatggcyttrtcrtt 
target: NDKAISPPKN 
95.8, 97.1  62.1, 55.3  58.9, 47.6 
L gene, no. 2,¶ nt 1962–2511 (550 
bp) 
L698F: catcaccgacctgtccaagttyaaycargc 
target: ITDLSKFNQA 
L894R: ttgaagtcgtccaggatggtrttdatcca 
target: WINTILDDFK 
96.7, 99.5  68.4, 71.6  66.4, 68.3 
*MPV, murine pneumovirus; nt, nucleotide; aa, amino acid; HRSV, human respiratory syncytial virus; HMPV, human metapneumovirus; N, nucleocapsid; 
R, reverse primer; F, forward primer L, polymerase.  
†Based on comparison with MPV strain J3666, GenBank accession no. NC_006579.  
‡Based on comparison with HRSV, GenBank accession no. NC_001803.  
§Based on comparison with HMPV, GenBank accession no. NC_004148. 
¶The N gene fragment is entered under GenBank accession no. GU247050; L gene fragments nos. 1 and 2 are entered under GenBank accession no. 
GU247051.  Pneumovirus in Dogs with Acute Respiratory Disease
determine pneumovirus prevalence among dogs and its in-
volvement in acute respiratory disease of dogs.
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